Latest News and Press Releases

New York, April 02, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD:...

Dublin, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The "Ketamine (CAS 6740-88-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...

The first-ever dedicated podcast recording area at a Psychedelic Science conference offers podcasters a prime location to capture conversations with scientists, policymakers, and industry leaders...

MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...

TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company seeking FDA approval for ketamine,...

Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the...

Psychemedics Corporation, a global leader in hair testing, announces the launch of its new ketamine hair testing solution.

Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "U.S. Ketamine Clinics Market Size, Share, & Trends Analysis Report By Treatment (Depression, Anxiety, PTSD, Others), By Therapy (On-site Therapy,...

Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Ketamine (CAS 6740-88-1) Global Market Research Report 2024" report has been added to ResearchAndMarkets.com's offering. This global report offers...

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its...